Momenta Pharmaceuticals, Inc.

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

Role: lead

Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated

Role: collaborator

Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis

Role: collaborator

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

Role: lead

An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis

Role: lead

Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)

Role: collaborator

Extension Study of MYL-1701P-3001 for Safety and Efficacy

Role: collaborator

Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics

Role: collaborator

Assessment of Pharmacokinetics and Safety of M923 Administered Via Auto-injector or Prefilled Syringe, in Healthy Subjects

Role: lead

Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)

Role: lead

An Ascending Dose Study to Evaluate M281 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)

Role: lead

Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis

Role: lead

M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

Role: lead

Usability of an AI for M923 in Subjects With Moderate to Severe RA

Role: lead

Assessment of Pharmacokinetics (PK) and Safety of M834 and Orencia ®, in Healthy Subjects

Role: lead